Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Open accessThe DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.
Abstract
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest, measured by right heart catheterisation. Recent data from normal subjects has shown that normal mPAP was 14.0±3.3 mmHg. Two standard deviations above this mean value would suggest mPAP >20 mmHg as above the upper limit of normal (above the 97.5th percentile). This definition is no longer arbitrary, but based on a scientific approach. However, this abnormal elevation of mPAP is not sufficient to define pulmonary vascular disease as it can be due to an increase in cardiac output or pulmonary arterial wedge pressure. Thus, this 6th WSPH Task Force proposes to include pulmonary vascular resistance ≥3 Wood Units in the definition of all forms of pre-capillary PH associated with mPAP >20 mmHg. Prospective trials are required to determine whether this PH population might benefit from specific management. Regarding clinical classification, the main Task Force changes were the inclusion in group 1 of a subgroup “pulmonary arterial hypertension (PAH) long-term responders to calcium channel blockers”, due to the specific prognostic and management of these patients, and a subgroup “PAH with overt features of venous/capillaries (pulmonary veno-occlusive disease/pulmonary capillary haemangiomatosis) involvement”, due to evidence suggesting a continuum between arterial, capillary and vein involvement in PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 The slope of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship is different in normal control versus pulmonary arterial hypertension (PAH) subjects. Reproduced and modified from [26] with permission.](https://figures.cochat.ai/paper-figures/36e057af8c4544adb1c352faf9a06761/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-1.jpg)
![FIGURE 2 Knowledge of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship does not allow distinction between left heart disease (LHD) and pulmonary vascular disease (PVD) patients; knowledge of exercise pulmonary arterial wedge pressure is also required. TPR: total pulmonary resistance; WU: Wood Units. Reproduced from [29] with permission.](https://figures.cochat.ai/paper-figures/8474dfd09d604465902cbdde1d1fd85a/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the World Symposium of Pulmonary Hypertension classification of PAH, group 1 is the most common indication.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Group 2, with decreased left ventricular function, is not an indication for transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Pulmonary hypertension can also occur in the context of congenital heart disease.(301)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [301]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“group 3 with PAH and accompanying pathological changes in the lung parenchyma can be considered for transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The current consensus is based on 2 tools for referral and listing: the REVEAL Registry 2.2 (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management 2.0) and 2015 European Society of Cardiology/European Respiratory Society.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationDe Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Self-citationClinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Self-citationDefinitions and Diagnosis of Pulmonary Hypertension
Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.032 · Cited by 1,766
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Self-citation
Research works printed but not linked: 2
- Reeves J , Dempsey J , Grover R . Pulmonary circulation during exercise. In: Weir EK , Reeves JT , eds. Pulmonary Vascular Physiology and Physiopathology. New York, Marcel Dekker, 1989; pp. 107–133. · doi:10.1201/9781003573739-5
- Tamura Y , Furukawa A , Li T , et al. Severe pulmonary arterial hypertension in patients treated by Chinese herb nature indigo: Qing-Dai. Poster presentation at the 6th World Symposium on Pulmonary Hypertension, Nice, 2018; A108.
Cited by
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
Self-citation2020 ESC Guidelines for the management of adult congenital heart disease
Baumgartner, H., De Backer, J., Babu-Narayan, S. V., Budts, W., Chessa, M., Diller, G.-P., lung, B., Kluin, J., Lang, I. M., Meijboom, F., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa554 · Cited by 2,311
Self-citation2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00879-2022 · Cited by 2,247
Self-citation2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J.-P., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa605 · Cited by 1,958
Chronic thromboembolic pulmonary hypertension
Kim, N. H., Delcroix, M., Jais, X., Madani, M. M., Matsubara, H., Mayer, E., Ogo, T., Tapson, V. F., Ghofrani, H.-A., & Jenkins, D. P. (2019) · European Respiratory Journal · doi:10.1183/13993003.01915-2018 · Cited by 1,007
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Risk stratification and medical therapy of pulmonary arterial hypertension
Galiè, N., Channick, R. N., Frantz, R. P., Grünig, E., Jing, Z. C., Moiseeva, O., Preston, I. R., Pulido, T., Safdar, Z., Tamura, Y., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01889-2018 · Cited by 819
Pulmonary Arterial Hypertension
Hassoun, P. M. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2000348 · Cited by 693
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Waxman, A., Restrepo-Jaramillo, R., Thenappan, T., Ravichandran, A., Engel, P., Bajwa, A., Allen, R., Feldman, J., Argula, R., Smith, P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2008470 · Cited by 666
Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review
Ruopp, N. F., & Cockrill, B. A. (2022) · JAMA · doi:10.1001/jama.2022.4402 · Cited by 643
Rosenzweig, E. B., Abman, S. H., Adatia, I., Beghetti, M., Bonnet, D., Haworth, S., Ivy, D. D., & Berger, R. M. F. (2019) · European Respiratory Journal · doi:10.1183/13993003.01916-2018 · Cited by 628
Definition, classification and diagnosis of pulmonary hypertension
Kovács, G., Bartolome, S., Denton, C. P., Gatzoulis, M. Α., Gu, S., Khanna, D., Badesch, D. B., & Montani, D. (2024) · European Respiratory Journal · doi:10.1183/13993003.01324-2024 · Cited by 593
Self-citationERS statement on chronic thromboembolic pulmonary hypertension
Delcroix, M., Torbicki, A., Gopalan, D., Sitbon, O., Klok, F. A., Lang, I., Jenkins, D., Kim, N. H., Humbert, M., Jais, X., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.02828-2020 · Cited by 576
Self-citationPulmonary hypertension due to left heart disease
Vachiéry, J.-L., Tedford, R. J., Rosenkranz, S., Palazzini, M., Lang, I., Guazzi, M., Coghlan, G., Chazova, I., & De Marco, T. (2019) · European Respiratory Journal · doi:10.1183/13993003.01897-2018 · Cited by 555
An overview of the 6th World Symposium on Pulmonary Hypertension
Galiè, N., McLaughlin, V. V., Rubin, L. J., & Simonneau, G. (2019) · European Respiratory Journal · doi:10.1183/13993003.02148-2018 · Cited by 526
Self-citationHansmann, G., Koestenberger, M., Alastalo, T.-P., Apitz, C., Austin, E. D., Bonnet, D., Budts, W., D'Alto, M., Gatzoulis, M. A., Hasan, B. S., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.06.022 · Cited by 444
Self-citationLung microbiome: new insights into the pathogenesis of respiratory diseases
Li, R., Li, J., & Zhou, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01722-y · Cited by 434
Lipshultz, S. E., Law, Y. M., Asante-Korang, A., Austin, E. D., Dipchand, A. I., Everitt, M. D., Hsu, D. T., Lin, K. Y., Price, J. F., Wilkinson, J. D., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000682 · Cited by 416
Thompson, A., Fleischmann, K. E., Smilowitz, N. R., de las Fuentes, L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001285 · Cited by 365
Nagueh, S. F., Sanborn, D. Y., Oh, J. K., Anderson, B., Billick, K., Derumeaux, G., Klein, A., Koulogiannis, K., Mitchell, C., Shah, A., et al. (2025) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2025.03.011 · Cited by 361
International Consensus Statement on Obstructive Sleep Apnea
Chang, J. L., Goldberg, A. N., Alt, J. A., Mohammed, A., Ashbrook, L., Auckley, D., Ayappa, I., Bakhtiar, H., Barrera, J. E., Bartley, B. L., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23079 · Cited by 350
Endothelial cells in the pathogenesis of pulmonary arterial hypertension
Evans, C. E., Cober, N. D., Dai, Z., Stewart, D. J., & Zhao, Y.-Y. (2021) · European Respiratory Journal · doi:10.1183/13993003.03957-2020 · Cited by 325
Maron, B. A., Brittain, E. L., Hess, E., Waldo, S. W., Barón, A. E., Huang, S., Goldstein, R. H., Assad, T. R., Wertheim, B. M., Alba, G. A., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30317-9 · Cited by 312
Self-citationSystemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure
Rosenkranz, S., Howard, L. S., Gomberg-Maitland, M., & Hoeper, M. M. (2020) · Circulation · doi:10.1161/circulationaha.116.022362 · Cited by 308
Reinero, C., Visser, L. C., Kellihan, H. B., Masseau, I., Rozanski, E., Clercx, C., Williams, K., Abbott, J., Borgarelli, M., & Scansen, B. A. (2020) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15725 · Cited by 302
Molecular genetic framework underlying pulmonary arterial hypertension
Southgate, L., Machado, R. D., Gräf, S., & Morrell, N. W. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0242-x · Cited by 301
Pulmonary Hypertension: A Brief Guide for Clinicians
Mandras, S. A., Mehta, H. S., & Vaidya, A. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.04.039 · Cited by 271
Nathan, S. D., Behr, J., Collard, H. R., Cottin, V., Hoeper, M. M., Martinez, F. J., Corte, T. J., Keogh, A. M., Leuchte, H., Mogulkoc, N., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30250-4 · Cited by 253
Treatment algorithm for pulmonary arterial hypertension
Chin, K. M., Gaine, S. P., Gerges, C., Jing, Z.-C., Mathai, S. C., Tamura, Y., McLaughlin, V. V., & Sitbon, O. (2024) · European Respiratory Journal · doi:10.1183/13993003.01325-2024 · Cited by 252
ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension
Yung, L.-M., Yang, P., Joshi, S., Augur, Z. M., Kim, S. S. J., Bocobo, G. A., Dinter, T., Troncone, L., Chen, P.-S., McNeil, M. E., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz5660 · Cited by 248
Peled, Y., Ducharme, A., Kittleson, M., Bansal, N., Stehlik, J., Amdani, S., Saeed, D., Cheng, R., Clarke, B., Dobbels, F., et al. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.05.010 · Cited by 240
Perivascular Inflammation in Pulmonary Arterial Hypertension
Hu, Y., Chi, L., Kuebler, W. M., & Goldenberg, N. M. (2020) · Cells · doi:10.3390/cells9112338 · Cited by 238
Pulmonary hypertension in bronchopulmonary dysplasia
Hansmann, G., Sallmon, H., Roehr, C. C., Kourembanas, S., Austin, E. D., Koestenberger, M., & for the European Pediatric Pulmonary Vascular Disease Network (EPPVDN) (2021) · Pediatric Research · doi:10.1038/s41390-020-0993-4 · Cited by 236
The physiological basis of pulmonary arterial hypertension
Naeije, R., Richter, M. J., & Rubin, L. J. (2022) · European Respiratory Journal · doi:10.1183/13993003.02334-2021 · Cited by 220
Verbrugge, F. H., Omote, K., Reddy, Y. N. V., Sorimachi, H., Obokata, M., & Borlaug, B. A. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab911 · Cited by 214
Thompson, A., Fleischmann, K. E., Smilowitz, N. R., de las Fuentes, L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.013 · Cited by 209
Boucly, A., Weatherald, J., Savale, L., de Groote, P., Cottin, V., Prévot, G., Chaouat, A., Picard, F., Horeau-Langlard, D., Bourdin, A., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02419-2021 · Cited by 207
Self-citationVascular toxic effects of cancer therapies
Herrmann, J. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0347-2 · Cited by 206
State-of-the-art evidence in the treatment of systemic sclerosis
Pope, J. E., Denton, C. P., Johnson, S. R., Fernandez-Codina, A., Hudson, M., & Nevskaya, T. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00909-5 · Cited by 206
Self-citationPulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances
Maron, B. A., Abman, S. H., Elliott, C. G., Frantz, R. P., Hopper, R. K., Horn, E. M., Nicolls, M. R., Shlobin, O. A., Shah, S. J., Kovacs, G., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202012-4317so · Cited by 202
Advances in the diagnosis and treatment of sickle cell disease
Brandow, A. M., & Liem, R. I. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01237-z · Cited by 199
The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure
Boucherat, O., Agrawal, V., Lawrie, A., & Bonnet, S. (2022) · Circulation Research · doi:10.1161/circresaha.121.319971 · Cited by 196
Luppi, F., Kalluri, M., Faverio, P., Kreuter, M., & Ferrara, G. (2021) · Respiratory Research · doi:10.1186/s12931-021-01711-1 · Cited by 194
Targeting transforming growth factor-β receptors in pulmonary hypertension
Guignabert, C., & Humbert, M. (2021) · European Respiratory Journal · doi:10.1183/13993003.02341-2020 · Cited by 192
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis
Hoeper, M. M., Dwivedi, K., Pausch, C., Lewis, R. A., Olsson, K. M., Huscher, D., Pittrow, D., Grünig, E., Staehler, G., Vizza, C. D., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00097-2 · Cited by 191
Pulmonary Hypertension: A Contemporary Review
Johnson, S., Sommer, N., Cox-Flaherty, K., Weissmann, N., Ventetuolo, C. E., & Maron, B. A. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202302-0327so · Cited by 190
Pathophysiology and new advances in pulmonary hypertension
Bousseau, S., Fais, R. S., Gu, S., Frump, A. L., & Lahm, T. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000137 · Cited by 188
Metabolism in Pulmonary Hypertension
Xu, W., Janocha, A. J., & Erzurum, S. C. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-123956 · Cited by 187
Poch, D., & Mandel, J. (2021) · Annals of Internal Medicine · doi:10.7326/aitc202104200 · Cited by 187
Zamanian, R. T., Badesch, D., Chung, L., Domsic, R. T., Medsger, T., Pinckney, A., Keyes-Elstein, L., D’Aveta, C., Spychala, M., White, R. J., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3481oc · Cited by 186
Targeting smooth muscle cell phenotypic switching in vascular disease
Chakraborty, R., Chatterjee, P., Dave, J. M., Ostriker, A. C., Greif, D. M., Rzucidlo, E. M., & Martin, K. A. (2021) · JVS-Vascular Science · doi:10.1016/j.jvssci.2021.04.001 · Cited by 183
Liem, R. I., Lanzkron, S., D. Coates, T., DeCastro, L., Desai, A. A., Ataga, K. I., Cohen, R. T., Haynes, J., Osunkwo, I., Lebensburger, J. D., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000916 · Cited by 182
Pulmonary hypertension associated with lung diseases
Shlobin, O. A., Adir, Y., Barberà, J. A., Cottin, V., Harari, S. A., Jutant, E., Pepke‐Żaba, J., Ghofrani, H. A., & Channick, R. N. (2024) · European Respiratory Journal · doi:10.1183/13993003.01200-2024 · Cited by 179
Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy
Al-Omary, M. S., Sugito, S., Boyle, A., Sverdlov, A. L., & Collins, N. J. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14330 · Cited by 178
Budts, W., Pieles, G. E., Roos‐Hesselink, J. W., la Garza, M. S., D’Ascenzi, F., Giannakoulas, G. A., Müller, J., Oberhoffer, R., Ehringer-Schetitska, D., Herceg-Čavrak, V., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa501 · Cited by 177
Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension
Gorelova, A., Berman, M., & Al Ghouleh, I. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8169 · Cited by 176
Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders
Sydykov, A. S., Mamazhakypov, A., Maripov, A., Kosanovic, D., Weißmann, N., Ghofrani, H. A., Шогаибович, С. А., & SCHERMULY, R. T. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041692 · Cited by 170
Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?
Kurakula, K., Smolders, V. F. E. D., Tura-Ceide, O., Jukema, J. W., Quax, P. H. A., & Goumans, M. (2021) · Biomedicines · doi:10.3390/biomedicines9010057 · Cited by 168
Jone, P., Ivy, D. D., Hauck, A. L., Karamlou, T., Truong, U. T., Coleman, R. D., Sandoval, J. P., Marín, M. J. D. C., Eghtesady, P., Tillman, K. A., et al. (2023) · Circulation Heart Failure · doi:10.1161/hhf.0000000000000080 · Cited by 168
Sleep-related breathing disorders and pulmonary hypertension
Adir, Y., Humbert, M. J. C., & Chaouat, A. (2020) · European Respiratory Journal · doi:10.1183/13993003.02258-2020 · Cited by 167
Greif, R., Bray, J. E., Djärv, T., Drennan, I. R., Liley, H. G., Ng, K.-C., Cheng, A., Douma, M. J., Scholefield, B. R., Smyth, M., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001288 · Cited by 166
Current and future treatments of pulmonary arterial hypertension
Sommer, N., Ghofrani, H. A., Pak, O., Bonnet, S., Provencher, S., Sitbon, O., Rosenkranz, S., Hoeper, M. M., & Kiely, D. G. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15016 · Cited by 166
The 6th World Symposium on Pulmonary Hypertension: what’s old is new
Condon, D. F., Nickel, N. P., Anderson, R. J., Mirza, S., & Pérez, V. D. J. (2019) · F1000Research · doi:10.12688/f1000research.18811.1 · Cited by 166
Exercise Pulmonary Hypertension Predicts Clinical Outcomes in Patients With Dyspnea on Effort
Ho, J. E., Zern, E. K., Lau, E. S., Wooster, L., Bailey, C. S., Cunningham, T., Eisman, A. S., Hardin, K. M., Farrell, R., Sbarbaro, J. A., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.048 · Cited by 165
Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension
Alabed, S., Shahin, Y., Garg, P., Alandejani, F., Johns, C., Lewis, R. A., Condliffe, R. A., Wild, J. M., Kiely, D. G., & Swift, A. J. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.08.013 · Cited by 164
Chronic thromboembolic pulmonary disease
Kim, N. H., D’Armini, A. M., Delcroix, M., Jaïs, X., Jevnikar, M., Madani, M. M., Matsubara, H., Palazzini, M., Wiedenroth, C. B., Simonneau, G., et al. (2024) · European Respiratory Journal · doi:10.1183/13993003.01294-2024 · Cited by 164
Self-citationSex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure
Hester, J., Ventetuolo, C., & Lahm, T. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c190011 · Cited by 160
Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension
Boucly, A., Cottin, V., Nunès, H., Jaïs, X., Tazi, A., Prévôt, G., Reynaud‐Gaubert, M., Dromer, C., Viacroze, C., Horeau-Langlard, D., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00465-2017 · Cited by 159
Self-citationTemporal trends in pulmonary arterial hypertension: results from the COMPERA registry
Hoeper, M. M., Pausch, C., Grünig, E., Staehler, G., Huscher, D., Pittrow, D., Olsson, K. M., Vizza, C. D., Gall, H. J., Distler, O., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.02024-2021 · Cited by 159
Omote, K., Sorimachi, H., Obokata, M., Reddy, Y. N. V., Verbrugge, F. H., Omar, M., DuBrock, H. M., Redfield, M. M., & Borlaug, B. A. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac184 · Cited by 155
Wang, R., Yuan, T., Wang, J., Chen, Y., Zhao, J., Li, M., Fang, L., & Du, G. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106238 · Cited by 154
Huertas, A., Tu, L., Humbert, M. J. C., & Guignabert, C. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz308 · Cited by 153
BMPR2 Mutation and Metabolic Reprogramming in Pulmonary Arterial Hypertension
Cuthbertson, I., Morrell, N. W., & Caruso, P. (2023) · Circulation Research · doi:10.1161/circresaha.122.321554 · Cited by 149
Rajagopal, S., Ruetzler, K., Ghadimi, K., Horn, E. M., Kelava, M., Kudelko, K. T., Moreno‐Duarte, I., Preston, I. R., Bovino, L. R., Smilowitz, N. R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001136 · Cited by 149
Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure
Maron, B. A., Kovács, G., Vaidya, A., Bhatt, D. L., Nishimura, R. A., Mak, S. S., Guazzi, M., & Tedford, R. J. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.10.007 · Cited by 142
Kawakami, T., Matsubara, H., Shinke, T., Abe, K., Kohsaka, S., Hosokawa, K., Taniguchi, Y., Shimokawahara, H., Yamada, Y., Kataoka, M., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(22)00171-0 · Cited by 142
Pulmonary Hypertension in Patients With COPD
Vizza, C. D., Hoeper, M. M., Huscher, D., Pittrow, D., Benjamin, N., Olsson, K. M., Ghofrani, H. A., Held, M., Klose, H. F. E., Lange, T. J., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.02.012 · Cited by 141
Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America
Bloom, M. W., Vo, J. B., Rodgers, J. E., FERRARI, A. M., Nohria, A., Deswal, A. M., Cheng, R. K.-H., Kittleson, M. M., Upshaw, J. N., Palaskas, N. L., et al. (2024) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.08.045 · Cited by 140
Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue
Caminati, A., Lonati, C., Cassandro, R., Elia, D., Pelosi, G., Torre, O., Zompatori, M., Uslenghi, E., & Harari, S. A. (2019) · European Respiratory Review · doi:10.1183/16000617.0044-2019 · Cited by 139
McLaughlin, V. V., Vachiéry, J., Oudiz, R. J., Rosenkranz, S., Galiè, N., Barberà, J. A., Frost, A., Ghofrani, H. A., Peacock, A. J., Simonneau, G., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.09.010 · Cited by 138
Self-citationAdaptive Versus Maladaptive Right Ventricular Remodelling
Rako, Z. A., Kremer, N., Yogeswaran, A., Richter, M. J., & Tello, K. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14233 · Cited by 137
Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society
Rémy‐Jardin, M., Ryerson, C. J., Schiebler, M. L., Leung, A. N. C., Wild, J. M., Hoeper, M. M., Alderson, P. O., Goodman, L. R., Mayo, J. R., Haramati, L. B., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04455-2020 · Cited by 136
Zhu, N., Pauciulo, M. W., Welch, C. L., Lutz, K. A., Coleman, A. W., Gonzaga-Jauregui, C., Wang, J., Grimes, J. M., Martin, L. J., He, H., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0685-z · Cited by 135
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
Lewis, R. A., Durrington, C., Condliffe, R. A., & Kiely, D. G. (2020) · European Respiratory Review · doi:10.1183/16000617.0009-2020 · Cited by 135
Potus, F., Pauciulo, M. W., Cook, E. K., Zhu, N., Hsieh, A., Welch, C. L., Shen, Y., Tian, L., Lima, P., Mewburn, J. D., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044320 · Cited by 133
Pulmonary arterial hypertension: updates in epidemiology and evaluation of patients
Levine, D. J. (2021) · The American Journal of Managed Care · doi:10.37765/ajmc.2021.88609 · Cited by 133
Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension
Saygın, D., Tabib, T., Bittar, H. E. T., Valenzi, E., Sembrat, J., Chan, S. Y., Rojas, M. M., & Lafyatis, R. (2020) · Pulmonary Circulation · doi:10.1177/2045894020908782 · Cited by 131
Huston, J., Maron, B. A., French, J. K., Huang, S., Thayer, T. E., Farber‐Eger, E. H., Wells, Q. S., Choudhary, G., Hemnes, A. R., & Brittain, E. L. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.3345 · Cited by 130
Hemodynamics for the Heart Failure Clinician: A State-of-the-Art Review
Hsu, S., Fang, J. C., & Borlaug, B. A. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.07.012 · Cited by 130
Endothelial upregulation of mechanosensitive channel Piezo1 in pulmonary hypertension
Wang, Z., Chen, J., Babicheva, A., Jain, P., Rodriguez, M., Ayon, R. J., Ravellette, K. S., Wu, L., Balistrieri, F., Tang, H., et al. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00147.2021 · Cited by 128
Price, L. C., Martinez, G. C., Brame, A., Pickworth, T., Samaranayake, C. B., Alexander, D. J., Garfield, B. E., Aw, T., McCabe, C., Mukherjee, B., et al. (2021) · British Journal of Anaesthesia · doi:10.1016/j.bja.2021.01.005 · Cited by 126
Self-citationScreening for pulmonary arterial hypertension in adults carrying aBMPR2mutation
Montani, D., Girerd, B., Jaïs, X., Laveneziana, P., Lau, E., Bouchachi, A., Hascoët, S., Günther, S., Godinas, L., Parent, F., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.04229-2020 · Cited by 125
Self-citationPulmonary hypertension associated with left heart disease
Maron, B. A., Bortman, G., Marco, T. D., Huston, J., Lang, I. M., Rosenkranz, S. L., Vachiéry, J., & Tedford, R. J. (2024) · European Respiratory Journal · doi:10.1183/13993003.01344-2024 · Cited by 125
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis
Denton, C. P., Lorenzis, E. D., Roblin, E., Goldman, N. R., Alcacer‐Pitarch, B., Blamont, E., Buch, M. H., Carulli, M., Cotton, C., Galdo, F. D., et al. (2024) · Rheumatology · doi:10.1093/rheumatology/keae394 · Cited by 125
Self-citationEstablished and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease
Tzoumas, N., Farrah, T. E., Dhaun, N., & Webb, D. J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14920 · Cited by 123
Approach to Pulmonary Arteriovenous Malformations: A Comprehensive Update
Majumdar, S., & McWilliams, J. P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061927 · Cited by 123
Evaluation and management of pulmonary arterial hypertension
Beshay, S. M., Sahay, S., & Humbert, M. J. C. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106099 · Cited by 123
Sex and gender in pulmonary arterial hypertension
Cheron, C., McBride, S. A., Antigny, F., Girerd, B., Chouchana, M., Chaumais, M., Jaïs, X., Bertoletti, L., Sitbon, O., Weatherald, J. C., et al. (2021) · European Respiratory Review · doi:10.1183/16000617.0330-2020 · Cited by 117
Self-citationLindley, K. J., Merz, C. N. B., Asgar, A., Bello, N. A., Chandra, S., Davis, M. B., Gomberg‐Maitland, M., Gulati, M., Hollier, L. M., Krieger, E. V., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.026 · Cited by 116
Interstitial Pneumonia with Autoimmune Features
Graney, B. A., & Fischer, A. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201808-565cme · Cited by 115
Metadata
- Authors
- Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R.
- Affiliations
- Université Paris-Sud (FR)
- The University of Sydney (AU)
- The Royal Free Hospital (GB)
- Mayo Clinic (US)
- Milpark Hospital (ZA)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801913
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351336
- OpenAlex
- W2904180601
- Cited by
- 3,813
- References
- 87
- Citations by year
- 2026: 208 · 2025: 356 · 2024: 480 · 2023: 541 · 2022: 716 · 2021: 711 · 2020: 558 · 2019: 225
- FWCI
- 282.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0033)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Keywords
- pulmonary hypertension, clinical classification, precapillary pulmonary hypertension, pulmonary arterial hypertension, pulmonary vascular resistance, mean pulmonary artery pressure, pulmonary vascular disease, pulmonary veno-occlusive disease, calcium channel blockers, right heart catheterization, reference values
- MeSH terms
- Consensus Statements as Topic, Heart Diseases, Hemodynamics, Humans, Hypertension, Pulmonary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.